The above chart shows Pfizer's revenue percentage share by geographical region.
In fiscal year 2023, Pfizer's revenue by region is as follows:
- Developed Europe generated $11.65 B in revenue, representing 19.92% of its total revenue.
- Developed Rest Of World generated $7.76 B in revenue, representing 13.27% of its total revenue.
- Emerging Markets generated $12.00 B in revenue, representing 20.51% of its total revenue.
- UNITED STATES generated $27.09 B in revenue, representing 46.31% of its total revenue.
The
biggest region for Pfizer is the UNITED STATES, which represents 46.31% of its total revenue.
The
smallest region for Pfizer is the Developed Rest Of World, which represents 13.27% of its total revenue.
The above chart shows Pfizer's revenue percentage share by geographical region.
In fiscal year 2024, Pfizer's revenue by region is as follows:
- Developed Rest Of World generated $16.06 B in revenue, representing 25.24% of its total revenue.
- Emerging Markets generated $8.88 B in revenue, representing 13.95% of its total revenue.
- UNITED STATES generated $38.69 B in revenue, representing 60.81% of its total revenue.
The
biggest region for Pfizer is the UNITED STATES, which represents 60.81% of its total revenue.
The
smallest region for Pfizer is the Emerging Markets, which represents 13.95% of its total revenue.
The above chart shows Pfizer's revenue percentage share by geographical region.
In fiscal year 2025, Pfizer's revenue by region is as follows:
- Developed Rest Of World generated $16.19 B in revenue, representing 25.87% of its total revenue.
- Emerging Markets generated $9.31 B in revenue, representing 14.88% of its total revenue.
- UNITED STATES generated $37.08 B in revenue, representing 59.25% of its total revenue.
The
biggest region for Pfizer is the UNITED STATES, which represents 59.25% of its total revenue.
The
smallest region for Pfizer is the Emerging Markets, which represents 14.88% of its total revenue.
Submit Feedback
